佛慈制药：2025年前三季度净利润约3808万元

Group 1 - The core viewpoint of the article highlights the financial performance of 佛慈制药 for the third quarter of 2025, indicating a decline in revenue and net profit compared to the previous year [1] - The company's revenue for the first three quarters of 2025 is approximately 624 million yuan, representing a year-on-year decrease of 11.92% [1] - The net profit attributable to shareholders of the listed company is about 38.08 million yuan, showing a year-on-year decline of 2.54% [1] - The basic earnings per share is reported at 0.0746 yuan, which is a decrease of 2.48% year-on-year [1] Group 2 - As of the report, 佛慈制药 has a market capitalization of 4.6 billion yuan [2]